Visfatin -948G/T and resistin -420C/G polymorphisms in Egyptian type 2 diabetic patients with and without cardiovascular diseases (Q39274448)

10 September 2017

title

Visfatin -948G/T and resistin -420C/G polymorphisms in Egyptian type 2 diabetic patients with and without cardiovascular diseases (English)

1 reference

10 September 2017

main subject

cardiovascular disease

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25120107%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Olfat G. Shaker

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25120107%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Maha M El-Sawalhi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25120107%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Zeinab M Abdel-Nasser

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25120107%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

publication date

1 May 2014

1 reference

10 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25120107%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25120107%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25120107%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

259-266

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25120107%20AND%20SRC:MED&resulttype=core&format=json

Adipokines: the missing link between insulin resistance and obesity.

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Common polymorphisms in the promoter of the visfatin gene (PBEF1) influence plasma insulin levels in a French-Canadian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Association of resistin gene polymorphisms with insulin resistance in Egyptian obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Resistin release by human adipose tissue explants in primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Retraction: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Insulin resistance as the core defect in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Role of adipocytokines in predicting the development of diabetes and its late complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Resistin gene promoter region polymorphism and the risk of hypertrophic cardiomyopathy in patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Resistin: functional roles and therapeutic considerations for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

The visfatin (PBEF1) G-948T gene polymorphism is associated with increased high-density lipoprotein cholesterol in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

NAMPT (visfatin) and AKT1 genetic variants associate with myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: the Korean atherosclerosis study (KAS): a 42-month prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Resistin gene variations are associated with the metabolic syndrome in Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Plasma resistin levels correlate with determinants of the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Genetic variation in the visfatin (PBEF1/NAMPT) gene and type 2 diabetes in the Greek population

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Visfatin/Nampt: an adipokine with cardiovascular impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Visfatin, glucose metabolism and vascular disease: a review of evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Adipose tissue: from lipid storage compartment to endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Global estimates of the prevalence of diabetes for 2010 and 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

The +299(G>A) resistin gene polymorphism and susceptibility to type 2 diabetes in Thais

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Polymorphism in resistin promoter region at -420 determines the serum resistin levels and may be a risk marker of stroke in Japanese type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Genetic variants at the resistin locus are associated with the plasma resistin concentration and cardiovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Association between resistin gene -420 C/G polymorphism and the risk of type 2 diabetes mellitus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Genetic variant in visfatin gene promoter is associated with decreased risk of coronary artery disease in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Nicotinamide Phosphoribosyltransferase in Human Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

A visfatin promoter polymorphism is associated with low-grade inflammation and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

Effects of genetic variation in the visfatin gene (PBEF1) on obesity, glucose metabolism, and blood pressure in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FGEN-2014-0022

21 January 2018

Identifiers

DOI

10.1139/GEN-2014-0022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25120107%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference